Stephen Kaler

Professor of Pediatrics, Division of Clinical Genetics · New York Presbyterian Hospital

Credentials: · · · · · ·

History

Viral Gene Therapy for Menkes Disease
National Institute of Neurological Disorders and Stroke · U01
Contact PI · $3.8M · Columbia University Health Sciences
2023–2028
Choroid Plexus-Directed Gene Therapy for Alpha-Mannosidosis
National Institute of Child Health and Human Development · U01
PI · $1.1M · Children's Hosp of Philadelphia
2014–2018
Inherited Disorders of Copper Transport
National Institute of Child Health and Human Development · ZIA
Contact PI · $5.5M · Eunice Kennedy Shriver National Institute of Child Health & Human Development
Mechanisms of Motor Neuron Disease
National Institute of Child Health and Human Development · ZIA
Contact PI · $2.2M · Eunice Kennedy Shriver National Institute of Child Health & Human Development

NORTHERA (DROXIDOPA) for Dysautonomia in Pediatric Survivors of Menkes Disease
Principal investigator · Recruiting · Phase 1, Phase 2
Stephen G. Kaler
2026–2030
NORTHERA (DROXIDOPA) for Dysautonomia in Adult Survivors of Menkes Disease and Occipital Horn Syndrome
Principal investigator · Completed · Phase 1, Phase 2
Stephen G. Kaler, MD
2021–2024
Clinical Biomarkers in Alpha-mannosidosis
Principal investigator · Completed
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
2014–2019
Copper Histidine Therapy for Menkes Diseases
Principal investigator · Completed · Phase 1, Phase 2
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
1990–2013